Down-Regulation of SIX3 is Associated with Clinical Outcome in Lung Adenocarcinoma

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Mo, Min Li ^a   Okamoto, Junichi ^b,c   Chen, Zhao ^a,b   Hirata, Tomomi ^b,c   Mikami, Iwao ^b,c   Bosco Clément, Geneviève ^b   Li, Hui ^b   Zhou, Hai Meng ^a   Jablons, David M ^b   He, Biao ^b  

^a TSINGHUA UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BAG1 PROTEIN; CELL PROTEIN; GINS3 PROTEIN; MESSENGER RNA; PROTEIN S 100; TRANSCRIPTION FACTOR SIX3; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CELL ASSAY; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WOUND HEALING;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; DNA METHYLATION; DOWN-REGULATION; EYE PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HOMEODOMAIN PROTEINS; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; TRANSCRIPTOME; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84882706613     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071816     Document Type: Article

References (39)

1. Parkin DM, (2001) Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543.
2. Gridelli C, Langer C, Maione P, Rossi A, Schild SE, (2007) Lung cancer in the elderly. J Clin Oncol 25: 1898-1907.
3. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43-66.
4. Wang L, Soria JC, Kemp BL, Liu DD, Mao L, et al. (2002) hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer. Clin Cancer Res 8: 2883-2889.
5. Zheng Z, Chen T, Li X, Haura E, Sharma A, et al. (2007) DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. N Engl J Med 356: 800-808.
6. Ramirez de Molina A, Sarmentero-Estrada J, Belda-Iniesta C, Taron M, Ramirez de Molina V, et al. (2007) Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study. Lancet Oncol 8: 889-897.
7. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, et al. (2007) A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356: 11-20.
8. Lau SK, Boutros PC, Pintilie M, Blackhall FH, Zhu CQ, et al. (2007) Three-gene prognostic classifier for early-stage non small-cell lung cancer. J Clin Oncol 25: 5562-5569.
9. Kratz JR, He J, Van Den Eeden SK, Zhu ZH, Gao W, et al. (2012) A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet 379: 823-832.
10. Rauch T, Wang Z, Zhang X, Zhong X, Wu X, et al. (2007) Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci U S A 104: 5527-5532.
11. Lopez-Rios J, Tessmar K, Loosli F, Wittbrodt J, Bovolenta P, (2003) Six3 and Six6 activity is modulated by members of the groucho family. Development 130: 185-195.
12. Fackler MJ, McVeigh M, Mehrotra J, Blum MA, Lange J, et al. (2004) Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 64: 4442-4452.
13. Grote HJ, Schmiemann V, Geddert H, Bocking A, Kappes R, et al. (2006) Methylation of RAS association domain family protein 1A as a biomarker of lung cancer. Cancer 108: 129-134.
14. Grote HJ, Schmiemann V, Geddert H, Rohr UP, Kappes R, et al. (2005) Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer. Int J Cancer 116: 720-725.
15. Kempkensteffen C, Christoph F, Weikert S, Krause H, Kollermann J, et al. (2006) Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors. J Cancer Res Clin Oncol 132: 765-770.
16. Harden SV, Tokumaru Y, Westra WH, Goodman S, Ahrendt SA, et al. (2003) Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res 9: 1370-1375.
17. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
18. Holm S, (1979) A Simple Sequentially Rejective Multiple Test Procedure. Scand J Statist 6: 65-70.
19. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
20. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
21. Therneau T, Atkinson E (1997) An introduction to recursive partitioning using the RPART routines. Rochester, MN: Mayo Foundation.
22. Harrell FE Jr, Lee KL, Mark DB, (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15: 361-387.
23. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, et al. (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8: 816-824.
24. Bianchi F, Nuciforo P, Vecchi M, Bernard L, Tizzoni L, et al. (2007) Survival prediction of stage I lung adenocarcinomas by expression of 10 genes. J Clin Invest 117: 3436-3444.
25. Raponi M, Zhang Y, Yu J, Chen G, Lee G, et al. (2006) Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res 66: 7466-7472.
26. Reed CE, Graham A, Hoda RS, Khoor A, Garrett-Mayer E, et al. (2008) A simple two-gene prognostic model for adenocarcinoma of the lung. J Thorac Cardiovasc Surg 135: 627-634.
27. Donato R, (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33: 637-668.
28. Zimmer DB, Wright Sadosky P, Weber DJ, (2003) Molecular mechanisms of S100-target protein interactions. Microsc Res Tech 60: 552-559.
29. Heizmann CW, Fritz G, Schafer BW, (2002) S100 proteins: structure, functions and pathology. Front Biosci 7: d1356-1368.
30. Marenholz I, Heizmann CW, Fritz G, (2004) S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322: 1111-1122.
31. Petrella BL, Armstrong DA, Vincenti MP, (2012) Interleukin-1 beta and transforming growth factor-beta 3 cooperate to activate matrix metalloproteinase expression and invasiveness in A549 lung adenocarcinoma cells. Cancer Lett 325: 220-226.
32. Nagahama Y, Ueno M, Haraguchi N, Mori M, Takakura N, (2010) PSF3 marks malignant colon cancer and has a role in cancer cell proliferation. Biochem Biophys Res Commun 392: 150-154.
33. Liu H, Liang Y, Li Y, Wang J, Wu H, et al. (2010) Gene silencing of BAG-1 modulates apoptotic genes and sensitizes lung cancer cell lines to cisplatin-induced apoptosis. Cancer Biol Ther 9: 832-840.
34. Ganesan K, Ivanova T, Wu Y, Rajasegaran V, Wu J, et al. (2008) Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene. Cancer Res 68: 4277-4286.
35. Raz DJ, Kim JY, Jablons DM, (2007) Diagnosis and treatment of bronchioloalveolar carcinoma. Curr Opin Pulm Med 13: 290-296.
36. Raz DJ, He B, Rosell R, Jablons DM, (2006) Bronchioloalveolar carcinoma: a review. Clin Lung Cancer 7: 313-322.
37. Raz DJ, He B, Rosell R, Jablons DM, (2006) Current concepts in bronchioloalveolar carcinoma biology. Clin Cancer Res 12: 3698-3704.
38. Coate LE, John T, Tsao MS, Shepherd FA, (2009) Molecular predictive and prognostic markers in non-small-cell lung cancer. The lancet oncology 10: 1001-1010.
39. Okamoto J, Kratz JR, Hirata T, Mikami I, Raz D, et al. (2011) Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients. Clinical lung cancer 12: 237-244.